Cas:266679-42-9 6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one manufacturer & supplier

Chemical Name:6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one

CAS.NO:266679-42-9

Synonyms:6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one

Molecular Formula:C₁₁H₇ClF₃N₃O

Molecular Weight:289.64100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:367.6ºC at 760mmHg

Density:1.54g/cm3

Index of Refraction:1.585

PSA:58.90000

Exact Mass:289.02300

LogP:3.00180

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one Use and application,6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one technical grade,usp/ep/jp grade.

Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one manufacturer The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one supplier Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. 6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one vendor Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. 6-(chloromethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrimidin-4-one factory Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.